Abnova provides an ISO15189 medical laboratory service to physicians and clinical researchers investigating circulating tumor DNA (ctDNA) released into the peripheral blood from tumor mass of cancer patients. Our capability is supported by a streamlined platform for ctDNA extraction, purification, library preparation and next-generation sequencing. ctDNA liquid biopsy is a precision tool for identifying and tracking cancer transformation and metastasis. It has significant clinical impact in cancer diagnosis, prognosis, treatment, and monitoring in the new era of personalized medicine.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
An interpretative report of the cancer gene mutations will be provided. | |
|
|
|
For any inquiry, please contact : OEM@abnova.com